SYNTHESIS
AND ANTIBACTERIAL ACTIVITY OF SOME A series of derivatives has been prepared from the antibiotic thermorubin, some of which show a substantial modification of the original structure.
The antibacterial activities are reported.
Thermorubin
(1) is an antibiotic produced by fermenting Thermoactinomyces antibioticus which was shown to possess a high activity against Gram-positive bacteria and a good activity against selected Gram-negative bacteria1)(see also Tables 1 and 2 ).
The protection previously shown1) (ED100 3 mg/kg) in mice infected intraperitoneally with Streptococcus pyogenes SKF 13400 has to be considered only indicative because the antibiotic was administered intraperitoneally. However, when tested under the same experimental conditions, it was inactive up to 200 mg/kg both by oral and subcutaneous administration, whereas it showed a certain degree of protection (approximately ED50 50 mg/kg) when administered iv (M. BERTI, personal communication).
The poor solubility in water and a substantial inactivation by serum proteins probably accounts for this lack of activity.
The mechanism of action of thermorubin was studied first by PIRALI et al. 2) who showed that it is bacteriostatic and acts on the protein synthesis by inhibiting the formation of the complex f Met-tRNAribosome -mRNA before the formation of the first peptidic bond. Recent studies3,4) on the nature of the complex thermorubin-ribosome showed that the inhibition occurs only in the presence of the initiation factors.
Following the determination of the structure5) a program for the chemical modification of thermorubin was established in an attempt to obtain derivatives with in vivo activity.
A series of compounds have been synthesized that are shown in Scheme 1. Due to the different chemical reactivity of the various functions present in thermorubin (1) treatment with conventional reagents gave both the expected derivatives and some compounds where the original structure was greatly modified. The preparation of compounds 5 to 9 and 12, and the assignment of the structures were previously reported6). The synthesis and some physico-chemical characteristics of compounds 2 to 4 and 10, 11 are described in the present paper together with some biological properties of all the compounds.
Chemistry
The general reaction pattern is reported in Scheme 1. diazomethane, led to the already known5) trimethylthermorubin (3).
Amides 4 and 5 were obtained by reacting 1 with aqueous solutions of ammonia and methylamine respectively. These reactions were carried out at -5°C and carefully monitored in order to prevent further reactions of the newly formed amides.
In particular, 5 reacts with another molecule of methylamine leading to 6 in which the unsaturated lacton ring is open and a N-methylketiminic group is formed at position 36) .
By allowing acid 2 to react with ethanolic methylamine compound 7 is obtained in which an unsaturated lactam ring is present instead of the lactonic one6) .
The sodium borohydride reduction of 1, in the presence of potassium dihydrogenphosphate necessary for the complete reaction of the starting material, gives the alcohol 8. During the neutralization of the large excess of the reducing reagent compound 9 is also formed6) . In this molecule, besides the reduction of the ester group, the 1,3-diketone is reduced too, while a lactonization between the carboxyl group of the acetic side chain and the newly formed hydroxyl group in position 1' occurred.
Derivatives of the acetic side chain in position 8 of thermorubin are difficult to obtain; no amides or esters could be obtained by means of the commonly used coupling reagents such as dicyclohexylcarbodiimide and carbonyldiimidazole. By allowing 1 to react in THF with a large excess of 2,2-dimethoxypropane7) under acidic catalysis the methyl ester 10 is isolated in good yields. Treatment of 1 with a 6: 1 complex of n-propylamine and PCl38) in THF gives small amounts of the amide 11.
Finally, 1 reacts with formaldehyde and several secondary amines under the Mannich reaction con-ditions9) giving in every case the same product 12 in which a methylenic group links the phenolic hydroxyl in position 2" at the 2' position.
In the Experimental section the procedures for the preparation of compounds 2 to 4 and 10, 11 1985 are reported together with some NMR data and MS values (obtained by Direct Inlet System LC-MS6)) which are relevant for the determination of the structures. The synthesis of compounds 5 to 9 and 12 has been described previouslyg6) .
Biological Properties and Structure-activity Relationships
The in vitro antibacterial activities (MIC) of the compounds are reported in Table 1 The in vitro activity of compounds 5 and 8 was also determined in comparison with thermorubin (1) against strains of Shigella and Salmonella and on Gram-positive and Gram-negative anaerobes. All the compounds had a comparable activity against Shigella and Salmonella strains. Thermorubin was more active than its derivatives on anaerobic bacteria, in particular on Propionibacterium acnes and Bacteroides fragilis; the activities of the other two compounds were generally comparable, but compound 5 was more active than compound 8 against 3 strains of B. fragilis ( Table 2 ).
The MIC of thermorubin and its derivatives 5 and 8 against staphylococci and E. coli in the absence and presence of bovine and horse serum and bovine albumin are shown in Table 3 . The presence of 30% serum strongly reduced the antibacterial activity of the compounds against all the strains tested;
there was a 1,024 to 32,000 fold increase in MIC of thermorubin and a 64 to 2,048 fold increase in MIC of its derivatives compared with the serum-free broth.
MIC of all the compounds were no more than 32 fold higher in the presence of 30% bovine albumin, with the exception of MIC of thermorubin which increased 128 times against Staphylococcus aureus ATCC 6538. An increase in serum from 30 to 50 % seems to have a more pronounced effect.
Against E. coli the decrease in activity of compounds 5 to 8 was difficult to compare with that of thermorubin because the derivatives precipitated at the high concentration in the presence of serum and albumin.
In Vivo Evaluation
In vivo activities of thermorubin (1) and compounds 4, 5 and 8 were compared by using a mouse model intraperitoneal infection with S. aureus TOUR. Compounds 4 and 8 were inactive up to 200 mg/kg both by oral and subcutaneous administration.
Compound 5 showed a slight improvement Melting points were determined in open glass capillaries, using a Buchi apparatus and are uncorrected.
The reactions were monitored by TLC on Kieselgel 60 F254 plates (Merck) developed with a mixture of CHCl3 -MeOH, 9: 1 and the spots detected by UV light at both 254 and 360 nm.
IR spectra were recorded as nujol mull with a Perkin-Elmer model 580 spectrophotometer. 1H NMR spectra were recorded at 270 MHz with a Brucker WH-270 spectrometer in DMSO-d6 solution with TMS as internal standard (0 0.00 ppm).
El mass spectrum of compound 10 was recorded on a Hitachi RMU-6L instrument with a Direct Insertion System (DIS) heated to 180°C, electron energy 70 eV, ion source temperature 250°C; the other compounds were analyzed by DIS LC/MS on a HP 5985 B instrument in both positive and negative ionization (only positive ions are reported in this paper). The instrument was equipped with a RP-MP RP-8 column (10 cm) eluted with CH3CN -H2O, 75: 25, CH3CN -THF -H2O, 70: 10: 20, or CH3CN -DMSO -H2O, 70: 10: 20, according to the compound solubilities. The eluents were also used as reactant gases for the chemical ionization.
Compound 2 A soln of 1 (2.0 g, 3.33 mmol) in 0.1 N NaOH (100 ml) was stirred for 2 hours at room temp, after which TLC indicated complete reaction. Ice was added then the reaction mixture was acidified with conc HCl and extracted with EtOAc (2 x 200 ml). The combined extracts were washed with H2O to neutrality and then dried (Na2SO4). Compound 3 A 1.5% soln of CH2N2 in dry ether (20 ml) was added dropwise to a soln of 2 (0.87 g, 1.48 mmol) in dry THF (50 ml). After five minutes the reaction was completed (TLC). AcOH (1 ml) was carefully added, followed by H2O (300 ml). The aqueous phase, made acidic with a few drops of HCl , was extracted with EtOAc (2 x 100 ml), the combined extracts were washed with H2O then dried over Na2SO4.
After concentration to a small vol crude 3 ppt by addition of petroleum ether (0.87 g). Pure 3 was obtained by column chromatography (silica gel Merck 0.06 ~ 0.2 mm loaded with 4.8% aqueous potassium dihydrogen phosphate, eluted with CHCl3 -MeOH, 99: 1) as a yellow ppt from CHCl3petroleum ether (0.1 g, 11 %); mp 118 ~ 120°C (ref5) 121 123°C).
Compound 4
A soln of 1 (3.0 g, 5 mmol) in 16% aqueous ammonia (70 ml) was stirred for 25 minutes at -5C , after which TLC revealed complete disappearance of the starting material. The reaction mixture was poured into ice and worked up as described for compound 2, obtaining 1. Compound 10 2,2-Dimethoxypropane (100 ml) and a few drops of 96% H2SO4 was added to a soln of 1 (2 .0 g, 3.33 mmol) in THE (70 ml). The reaction mixture was refluxed for 16 hours after which it was cooled to room temp and filtered. To the filtrate Na2CO3 (1 g) was added and the suspension stirred until acidity was no longer detected. After filtration the soln was concd to dryness and taken up in EtOAc. 
Compound 11
To a soln of n-propylamine (1.67 ml, 20 mmol) in dry THF (20 ml) cooled at 0°C, PCl3 (0.29 ml, 3.33 mmol) was added with stirring. The resulting soln was allowed to come to room temp after which 1 (3.0 g, 5 mmol), dissolved in 60 ml of dry THF, was added. The reaction mixture was warmed to 50°C and stirred for 2 hours. After this time TLC showed the disappearance of 1 and a predominant yellow spot (Rf 0.95) together with some spots of the decomposition compounds.
After cooling the reaction mixture was filtered from the undissolved material, diluted with H2O, acidified with a few drops of concd HCl and then extracted with EtOAc (2 x 200 ml). Crude 12 (1. Determination of Antibacterial Activity Minimal inhibitory concentration (MIC) was determined using the two-fold dilution method in microtiter system. The media used were : Brain heart infusion broth (Difco) supplemented with 2% bovine serum for streptococci; Antibiotic medium 3 (Difco) for staphylococci and Gram-negative bacteria. Anaerobic bacteria were tested on Schaedler agar supplemented with 1 % vitamine K1 and 1% hemin.
The final inoculum was approximately 103 and 102 colony-forming units (cfu) per ml for Grampositive and Gram-negative bacteria, respectively. Anaerobs were inoculated by multipoint inoculator (inoculum 104 cfu per spot) and incubated in anaerobic atmosphere (N2 -CO2 -H2, 80: 10: 10). MIC was read as the lowest concentration which showed no visible growth after incubation at 37°C for 18 ~ 24 hours or 48 hours (anaerobic bacteria). Experimental infection; groups of five mice were infected intraperitoneally with S. aurerts TOUR. Inocula were adjusted so that untreated animals died of septicemia within 48 hours. Animals were treated once daily for three days starting immediately after infection. On the 10th day the value for the ED54 in mg/kg/day was calculated by the method of SPEARMAN and KARBER10), on the basis of the percentage of surviving animals at each dose.
